When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Adamas Pharma bails on amantadine in MS patients with walking impairment
Adamas Pharmaceuticals Inc.
Citing "limited" commercial opportunity and the need to conduct another late-stage clinical trial, Adamas Pharmaceuticals (NASDAQ:ADMS) has decided to terminate development of ADS-5102 (amantadine) extended-release capsules for the treatment multiple sclerosis (MS) patients with walking impairment.
More news on: Adamas Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,